{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:52:02Z","timestamp":1787579522139,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jtcvsonline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jtcvs.2017.09.143","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T20:01:43Z","timestamp":1511467303000},"page":"1227-1235.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma"],"prefix":"10.1016","volume":"155","author":[{"given":"Fangfei","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2017.09.143_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6004\/jnccn.2015.0071","article-title":"Non-small cell lung cancer, version 6.2015","volume":"13","author":"Ettinger","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"Arriagada","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib4","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","article-title":"Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer","volume":"352","author":"Winton","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB\u2013IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib6","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(10)60059-1","article-title":"Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data","volume":"375","author":"Arriagada","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib9","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1200\/JCO.2009.24.0333","article-title":"Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10","volume":"28","author":"Butts","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib11","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","article-title":"Revisions in the International System for Staging Lung Cancer","volume":"111","author":"Mountain","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/JTO.0b013e31818b06e3","article-title":"The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer","volume":"3","author":"Travis","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/modpathol.2010.232","article-title":"Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases","volume":"24","author":"Yoshizawa","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib16","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1200\/JCO.2011.37.2185","article-title":"The novel histologic International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival","volume":"30","author":"Warth","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ijc.21933","article-title":"Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: long-term survival in a randomized study","volume":"119","author":"Roselli","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib18","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/annonc\/mdv008","article-title":"Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung\u00a0cancer \u22654 cm in size: a SEER-Medicare analysis","volume":"26","author":"Malhotra","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib19","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/JTO.0b013e318221f701","volume":"6","author":"Russell","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib20","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1200\/JCO.2013.50.1049","article-title":"Predictive value of the International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival","volume":"32","author":"Hung","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib21","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1200\/JCO.2015.60.9818","article-title":"Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival","volume":"33","author":"Ujiie","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib22","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/cncr.26584","article-title":"Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome","volume":"118","author":"Solis","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib23","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/djt166","article-title":"Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller","volume":"105","author":"Nitadori","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib24","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jtho.2016.06.014","article-title":"The clinical impact of solid and micropapillary patterns in resected lung adenocarcinoma","volume":"11","author":"Yanagawa","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib25","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1183\/09031936.00138813","article-title":"Relevance of the novel IASLC\/ATS\/ERS classification of lung adenocarcinoma in advanced disease","volume":"43","author":"Campos-Parra","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib26","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.2014.58.8335","article-title":"Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection","volume":"33","author":"Tsao","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib27","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00432-016-2192-6","article-title":"Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB","volume":"142","author":"Luo","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib28","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.athoracsur.2015.10.075","article-title":"Adjuvant chemotherapy improves the probability of freedom from recurrence in patients with resected stage IB lung adenocarcinoma","volume":"101","author":"Hung","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2017.09.143_bib29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JTO.0000000000000486","article-title":"Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas","volume":"10","author":"Kadota","year":"2015","journal-title":"J Thorac Oncol"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522317324339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522317324339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T01:16:04Z","timestamp":1583025364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522317324339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0022522317324339"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2017.09.143","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2017.09.143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}